Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 11, 2021
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
Tue, August 10, 2021
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
Joon Lee Maintained (AXSM) at Strong Buy with Decreased Target to $160 on, Aug 10th, 2021
Joon Lee of Truist Securities, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $200 to $160 on, Aug 10th, 2021.
Joon has made no other calls on AXSM in the last 4 months.
There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Joon's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joon
- Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $112 on, Thursday, June 10th, 2021
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $225 on, Tuesday, April 27th, 2021
